Method of enhanced immunogenicity to meningococcal vaccination

Details for Australian Patent Application No. 2004255526 (hide)

Owner Aventis Pasteur, Inc.

Inventors Ryall, Robert P.

Agent Spruson & Ferguson

Pub. Number AU-A-2004255526

PCT Pub. Number WO2005/004909

Priority 60/468,583 07.05.03 US

Filing date 7 May 2004

Wipo publication date 20 January 2005

International Classifications

A61K 039/095 Medicinal preparations containing antigens or antibodies - Neisseria

A61K 039/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 039/116 Medicinal preparations containing antigens or antibodies - Polyvalent bacterial antigens

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2005/004909 Priority application(s): WO2005/004909

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255529-Lottery game method

2004255522-Combination playhouse and doll carrying case